Trading Signals: SAGE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)(SAGE Therapeutics Inc)
| SAGE latest price $45.0200 (-1.6%) ($44.9500 - $45.0200) on Fri. Oct. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.35% (three month average) | RSI | 38 | Latest Price | $45.0200(-1.6%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SAGE advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SAGE advance at 0% a week (0% probability) IBB(50%) IWO(44%) IWC(43%) IWM(42%) IWN(37%) | Factors Impacting SAGE price | SAGE will decline at least -1.175% in a week (0% probabilities). VIXM(-28%) UUP(-12%) VXX(-6%) TBT(-3%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.175% (StdDev 2.35%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $45.14 | 5 Day Moving Average | $45.33(-0.68%) | 10 Day Moving Average | $45.18(-0.35%) | 20 Day Moving Average | $45.14(-0.27%) | To recent high | -7.2% | To recent low | 12% | Market Cap | $2.338b | | | | SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA. |